CRISPR Stock Price on July 3, 2022 Breakdown

CRSP
 Stock
  

USD 80.14  1.48  1.88%   

As of today, the current price of CRISPR Therapeutics is  80.14 , as last reported on the 16th of August 2022, with the highest price reaching  80.60  and the lowest price hitting  77.06  during the day.
CRISPR Therapeutics appears to be very steady, given 3 months investment horizon. CRISPR Therapeutics secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had 0.15% of return per unit of return volatility over the last 3 months. Our approach to foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. By reviewing CRISPR Therapeutics technical indicators you can today evaluate if the expected return of 0.75% is justified by implied risk. Please makes use of CRISPR Therapeutics' Risk Adjusted Performance of 0.2677, semi deviation of 4.4, and Mean Deviation of 3.92 to double-check if our risk estimates are consistent with your expectations.
  
As of 16th of August 2022, Net Income Common Stock is likely to grow to about 407.5 M. As of 16th of August 2022, Price to Book Value is likely to grow to 3.01. Also, Price to Earnings Ratio is likely to grow to 16.45. CRISPR Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Most Recent Activity

Shares Float
76.9 M
Shares Outstanding
78 M
Shares Short Prior Month
11.5 M
Earnings Share
3.76
Shares Short
11 M
Revenue Per Share
0.19

CRISPR Therapeutics Valuation on July 3, 2022

It is possible to determine the worth of CRISPR Therapeutics on a given historical date. On July 3, 2022 CRISPR was worth 61.92 at the beginning of the trading date compared to the closed value of 60.77. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CRISPR Therapeutics stock. Still, in general, we apply an absolute valuation method to find CRISPR Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CRISPR Therapeutics' related companies.
 Open High Low Close Volume
  62.76    63.90    61.00    63.00    1,714,737  
06/30/2022
  61.92    63.20    60.67    60.77    1,376,292  
  61.11    64.00    60.41    63.79    936,537  
Backtest CRISPR Therapeutics  |  CRISPR Therapeutics History  |  CRISPR Therapeutics Valuation   PreviousNext  
Open Value 61.92
60.77
Closing Value
76.67
Upside

CRISPR Therapeutics Trading Date Momentum on July 3, 2022

On July 01 2022 CRISPR Therapeutics AG was traded for  63.79  at the closing time. The top price for the day was 64.00  and the lowest listed price was  60.41 . The trading volume for the day was 936.5 K. The trading history from July 1, 2022 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 4.97% . The overall trading delta against the current closing price is 25.52% .

CRISPR Therapeutics Fundamentals Correlations and Trends

By evaluating CRISPR Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CRISPR Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CRISPR financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About CRISPR Therapeutics Stock history

CRISPR Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CRISPR is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CRISPR Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CRISPR Therapeutics historical stock prices may prove useful in developing a viable investing in CRISPR Therapeutics
Last ReportedProjected for 2022
Weighted Average Shares75.9 M62.1 M
Weighted Average Shares Diluted80.4 M64.9 M
Issuance Purchase of Equity Shares250.9 M284.5 M
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats CRISPR-associated protein 9 platform. CRISPR Therapeutics AG was incorporated in 2013 and is headquartered in Zug, Switzerland. CRISPR Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 473 people.

CRISPR Therapeutics Quarterly Market Capitalization

4.71 Billion

CRISPR Therapeutics Stock Technical Analysis

CRISPR Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of CRISPR Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of CRISPR Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

CRISPR Therapeutics Period Price Range

Low
June 30, 2022
High

 61.92 

  

 60.77 

-1.15-1.86%

CRISPR Therapeutics August 16, 2022 Market Strength

Market strength indicators help investors to evaluate how CRISPR Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CRISPR Therapeutics shares will generate the highest return on investment. By undertsting and applying CRISPR Therapeutics stock market strength indicators, traders can identify CRISPR Therapeutics AG entry and exit signals to maximize returns

CRISPR Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for CRISPR stock's direction in advance. Along with the technical and fundamental analysis of CRISPR Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CRISPR to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Continue to Trending Equities. Note that the CRISPR Therapeutics information on this page should be used as a complementary analysis to other CRISPR Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.

Complementary Tools for CRISPR Stock analysis

When running CRISPR Therapeutics price analysis, check to measure CRISPR Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CRISPR Therapeutics is operating at the current time. Most of CRISPR Therapeutics' value examination focuses on studying past and present price action to predict the probability of CRISPR Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CRISPR Therapeutics' price. Additionally, you may evaluate how the addition of CRISPR Therapeutics to your portfolios can decrease your overall portfolio volatility.
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Is CRISPR Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CRISPR Therapeutics. If investors know CRISPR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CRISPR Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
6.3 B
Quarterly Revenue Growth YOY
-1.0
Return On Assets
-0.15
Return On Equity
-0.27
The market value of CRISPR Therapeutics is measured differently than its book value, which is the value of CRISPR that is recorded on the company's balance sheet. Investors also form their own opinion of CRISPR Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CRISPR Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CRISPR Therapeutics' market value can be influenced by many factors that don't directly affect CRISPR Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CRISPR Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine CRISPR Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CRISPR Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.